‘Monumental’ and ‘highly meaningful’ advances across solid tumors highlight ESMO program

MADRID — Remarkable. Highly meaningful. Monumental.
These are just a sampling of adjectives used to describe late-breaking abstracts presented during presidential symposium sessions at this year’s ESMO Congress.
Multiple studies highlighted potential new standards that may provide clinically meaningful benefits to patients, according to investigators and key opinion leaders who were not involved with the research.
This Healio exclusive highlights three of those abstracts — spanning urothelial cancer, lung cancer and colorectal cancer — that have the potential to change

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.